Processa Pharmaceuticals, Inc. financial data

Symbol
PCSA on Nasdaq
Location
Vero Beach, FL
Fiscal year end
31 December
Latest financial report
18 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 315% % -30%
Debt-to-equity 35% % 32%
Return On Equity -258% % -11%
Return On Assets -191% % -3.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,660,039 shares -50%
Common Stock, Shares, Outstanding 2,571,914 shares 1637%
Entity Public Float $8,100,000 USD 40%
Common Stock, Value, Issued $257 USD 1613%
Weighted Average Number of Shares Outstanding, Basic 1,309,271 shares 969%
Weighted Average Number of Shares Outstanding, Diluted 1,309,271 shares 969%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $6,178,168 USD 29%
Operating Income (Loss) $13,988,505 USD -16%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,010,326 USD -15%
Net Income (Loss) Attributable to Parent $13,563,834 USD -14%
Earnings Per Share, Basic -10.36 USD/shares 89%
Earnings Per Share, Diluted -10.36 USD/shares 89%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,536,955 USD 365%
Assets, Current $5,670,874 USD 202%
Property, Plant and Equipment, Net $3,812 USD -24%
Operating Lease, Right-of-Use Asset $24,318 USD
Assets $7,813,567 USD 142%
Accounts Payable, Current $1,056,796 USD 20%
Accrued Liabilities, Current $1,179,457 USD 104%
Liabilities, Current $2,236,253 USD 46%
Operating Lease, Liability, Noncurrent $21,831 USD -80%
Liabilities $2,236,253 USD 46%
Retained Earnings (Accumulated Deficit) $100,783,033 USD -16%
Stockholders' Equity Attributable to Parent $5,577,314 USD 229%
Liabilities and Equity $7,813,567 USD 142%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,729,848 USD -33%
Net Cash Provided by (Used in) Financing Activities $4,435,595 USD -29%
Common Stock, Shares Authorized 1,000,000,000 shares 900%
Common Stock, Shares, Issued 2,572,114 shares 1634%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,705,747 USD -60%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,880 USD
Deferred Tax Assets, Valuation Allowance $21,325,736 USD 7.2%
Deferred Tax Assets, Gross $21,325,736 USD 7.2%
Operating Lease, Liability $21,832 USD -80%
Depreciation $301 USD 117%
Lessee, Operating Lease, Liability, to be Paid $23,347 USD -80%
Operating Lease, Liability, Current $21,832 USD -75%
Lessee, Operating Lease, Liability, to be Paid, Year One $70,040 USD -24%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,515 USD -77%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $857,550 USD 36%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%